Immune response profiling identifies autoantibodies specific to Moyamoya patients
Open Access
- 21 March 2013
- journal article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 8 (1) , 45
Abstract
Background: Moyamoya Disease is a rare, devastating cerebrovascular disorder characterized by stenosis/occlusion of supraclinoid internal carotid arteries and development of fragile collateral vessels. Moyamoya Disease is typically diagnosed by angiography after clinical presentation of cerebral hemorrhage or ischemia. Despite unclear etiology, previous reports suggest there may be an immunological component.Methods: To explore the role of autoimmunity in moyamoya disease, we used high-density protein arrays to profile IgG autoantibodies from the sera of angiographically-diagnosed Moyamoya Disease patients and compared these to healthy controls. Protein array data analysis followed by bioinformatics analysis yielded a number of auto-antibodies which were further validated by ELISA for an independent group of MMD patients (n = 59) and control patients with other cerebrovascular diseases including carotid occlusion, carotid stenosis and arteriovenous malformation.Results: We identified 165 significantly (p < 0.05) elevated autoantibodies in Moyamoya Disease, including those against CAMK2A, CD79A and EFNA3. Pathway analysis associated these autoantibodies with post-translational modification, neurological disease, inflammatory response, and DNA damage repair and maintenance. Using the novel functional interpolating single-nucleotide polymorphisms bioinformatics approach, we identified 6 Moyamoya Disease-associated autoantibodies against APP, GPS1, STRA13, CTNNB1, ROR1 and EDIL3. The expression of these 6 autoantibodies was validated by custom-designed reverse ELISAs for an independent group of Moyamoya Disease patients compared to patients with other cerebrovascular diseases.Conclusions: We report the first high-throughput analysis of autoantibodies in Moyamoya Disease, the results of which may provide valuable insight into the immune-related pathology of Moyamoya Disease and may potentially advance diagnostic clinical tools.Keywords
This publication has 59 references indexed in Scilit:
- Loss of BRCC3 Deubiquitinating Enzyme Leads to Abnormal Angiogenesis and Is Associated with Syndromic MoyamoyaThe American Journal of Human Genetics, 2011
- Protein Microarrays Discover Angiotensinogen and PRKRIP1 as Novel Targets for Autoantibodies in Chronic Renal DiseaseMolecular & Cellular Proteomics, 2011
- The Lys63-specific Deubiquitinating Enzyme BRCC36 Is Regulated by Two Scaffold Proteins Localizing in Different Subcellular CompartmentsJournal of Biological Chemistry, 2010
- Role of Wnt canonical pathway in hematological malignanciesJournal of Hematology & Oncology, 2010
- A Histone-Fold Complex and FANCM Form a Conserved DNA-Remodeling Complex to Maintain Genome StabilityMolecular Cell, 2010
- MHF1-MHF2, a Histone-Fold-Containing Protein Complex, Participates in the Fanconi Anemia Pathway via FANCMMolecular Cell, 2010
- Pericentrin in cellular function and diseaseJournal of Cell Biology, 2009
- Fe65 is required for Tip60-directed histone H4 acetylation at DNA strand breaksProceedings of the National Academy of Sciences, 2009
- Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signalingNature Genetics, 2007
- G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cellsJournal of Clinical Investigation, 2007